4-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)butyl monophosphate

ID: ALA574987

Chembl Id: CHEMBL574987

PubChem CID: 23263379

Max Phase: Preclinical

Molecular Formula: C8H13N2O6P

Molecular Weight: 264.17

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1ccn(CCCCOP(=O)(O)O)c(=O)[nH]1

Standard InChI:  InChI=1S/C8H13N2O6P/c11-7-3-5-10(8(12)9-7)4-1-2-6-16-17(13,14)15/h3,5H,1-2,4,6H2,(H,9,11,12)(H2,13,14,15)

Standard InChI Key:  GBNJFWXZTAZAOD-UHFFFAOYSA-N

Alternative Forms

Associated Targets(non-human)

P2ry2 Purinergic receptor P2Y2 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 264.17Molecular Weight (Monoisotopic): 264.0511AlogP: -0.57#Rotatable Bonds: 6
Polar Surface Area: 121.62Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 1.81CX Basic pKa: CX LogP: -0.87CX LogD: -3.91
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.47Np Likeness Score: -0.20

References

1. Sauer R, El-Tayeb A, Kaulich M, Müller CE..  (2009)  Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.,  17  (14): [PMID:19523835] [10.1016/j.bmc.2009.05.062]

Source